No. MCS is not “controlled by the brain” in the sense of conscious or subconscious choice. The brain and nervous system are part of the physical biology of the illness, just as they are in migraine, dysautonomia, chronic pain, TBI, and many other conditions. Brain involvement does not convert a physiological disorder into a psychological one.
The brain is part of the biology of MCS. “Brain involvement,” “psychological causation,” and “conscious control” are three different claims.
When people hear that the brain is involved in Multiple Chemical Sensitivity, the conversation often takes a wrong turn.
“If it is in the brain,” someone says, “then perhaps the person is creating it. Perhaps the brain learned the reaction. Perhaps the person can simply retrain the brain and stop it.”
That conclusion does not follow.
Repeated illness can teach the nervous system to anticipate danger and can teach the person to watch for environments that have made them sick before. That exposure vigilance is a consequence that can later interact with prediction, attention, and autonomic arousal. It is not evidence that conscious or subconscious thought authored the disease.
The causal question has to be answered by chronology and physiology: what changed first, what exposures preceded illness, what happened before the person knew what to avoid, and what changes when exposures are removed.
The brain is a physical organ. It receives information from sensory nerves, regulates autonomic functions, coordinates immune and endocrine signaling, predicts and interprets sensory input, and changes with experience, injury and illness. Showing that the brain participates in MCS tells us that MCS involves neurobiology. It does not tell us that the person consciously created the illness or can consciously switch it off.
The established MCS pattern is multisystem. People can report respiratory, neurological, gastrointestinal, cardiovascular, cognitive and other symptoms in response to low-level exposures to multiple unrelated chemicals, with improvement when the incitants are removed.
That kind of whole-body response virtually guarantees nervous-system participation. The autonomic nervous system helps regulate heart rate, blood pressure, sweating, breathing, digestion, pupil responses and many other functions. Sensory nerves detect chemical and physical stimuli. The central nervous system integrates those signals and determines how the body responds.
Most of this happens outside conscious control. A person does not consciously choose a cough reflex, a sudden change in heart rate, nausea, sweating, airway irritation or a sensory alarm response any more than a person consciously directs every heartbeat.
One of the clearest physiological findings comes from capsaicin challenge. Capsaicin activates TRPV1, a sensory receptor involved in detecting noxious heat and chemical stimuli and in triggering cough. In a double-blind randomized study, people meeting MCS criteria coughed more and reported more symptoms than healthy controls at comparable capsaicin doses. The authors concluded that airway sensory reactivity was increased.
This does not prove that TRPV1 is “the cause” of MCS. It does show that at least one sensory-response pathway can behave differently in people with MCS.
A review of 23 experimental human studies involving chemical intolerance found consistent evidence of altered neurological processing of sensory information, including differences in limbic and related cortical regions during or after exposure to odorous or pungent substances.
Brain imaging cannot tell us which event came first. A brain can change because of repeated exposure, chronic illness, sensitization, learning, stress, injury or combinations of these factors. The correct conclusion is therefore modest but important: neurological processing is altered. The incorrect conclusion is: because the brain is involved, the illness must be psychological.
A 2023 review by Molot, Sears and Anisman brought together evidence involving TRPV1 and TRPA1 sensory pathways, genetic influences, gene-environment interactions, oxidative stress, systemic inflammation, cellular dysfunction and psychosocial influences. The authors argued that sensitization of TRP receptors may be important in MCS.
We treat TRPV1 and TRPA1 as the strongest candidate and not as a finished explanation. The broader working model is environmental hyperresponsiveness: an acquired high-gain state in which sensory, central, autonomic, immune, inflammatory and metabolic systems may interact abnormally after an initiating event in a susceptible person.
In the 69-person randomized MCS trial of mindfulness-based cognitive therapy, participants changed how they thought and felt about the illness. Their illness perceptions improved. Yet the primary MCS outcome — symptoms, chemical reactions and life impact measured by the QEESI — did not improve.
That is a remarkably useful result for this question. The brain and cognition can change while the underlying MCS illness status does not.
The Canary Registry should help separate central amplification from the underlying environmental-response phenotype.
It should ask whether reactions occur when the trigger is known, when it is suspected, and when the person did not know it was present. It should record latency, symptom pattern, objective physiological findings when available, and whether calming techniques alter fear, symptom intensity, function or actual chemical tolerance.
The registry should also track prior TBI and PTSD as comparison variables. These conditions can involve persistent changes in neural processing and autonomic regulation, but they have very different initiating events. If certain MCS subgroups share features with them, that may teach us about downstream high-gain circuitry without proving shared causation.
The brain is deeply involved in MCS because the brain and nervous system are part of the body's environmental-response machinery.
Expectation, attention, conditioning, fear and stress can modify that machinery. They may amplify or dampen some responses after the condition exists. That is why nervous-system regulation can be a legitimate supportive tool.
But in people meeting the established MCS criteria, the evidence does not support replacing an environmental and physiological explanation with the claim that the person is consciously or subconsciously creating the illness.